(1,3,5-Trimethyl-1H-pyrazol-4-yl)-methanol, 95.0%, 5g

N-(Pyridin-4-ylmethyl)ethanamine, 97.0%, 100g

(5S)-5-methyl-3-(phenylthio)dihydrofuran-2(3H)-one, 98%, 5g

(S)-tert-Butyl (5-oxopyrrolidin-3-yl)carbamate, 95.0%, 10g

Stand plates stable position, 130 mm, 210 mm, 1 Piece

(2E)-3-(5-methylfuran-2-yl)-1-(3-nitrophenyl)prop-2-en-1-one, 95.0%, 10g

Thieno[3,4-b]pyrazine, 95%, 250mg

N-Allyl-2-amino-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide, 95.0%, 500mg

Cyclobutyl phenyl ketone, 98.0%, 25g

GC capillary column ROTI®Cap-1, 30 m, 0.53 mm, 5.00 µm, 1 Piece(s)

Octaethylene Glycol Monododecyl Ether>97.0%(GC)5g

{4-[1-(dimethylamino)ethyl]phenyl}boronic acid hydrochloride, 95.0%, 1g

N-[2-(Aminomethyl)phenyl]-N,N-dimethylamine, 95.0%, 5g